NFKB1 and breast carcinoma: However, lipopolysaccharide (LPS) is known to induce NF-κB activation in breast cancer cells30,31, so we treated 182R-6 cells with LPS, alone or in combination with the NF-κB inhibitor sc-514, and examined the expression of miR-22 and nuclear RelA/p65.